Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

CYCN Cyclerion Therapeutics Inc

2,99

0,08 (2,75%)

18 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

Cyclerion Therapeutics (NASDAQ:CYCN)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Cyclerion Therapeutics Charts.

Cyclerion Therapeutics (NASDAQ:CYCN)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Cyclerion Therapeutics Charts.

News Cyclerion Therapeutics Inc

Form 8-K - Current report
Dienstag 17 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth
Dienstag 17 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 7 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 7 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Regina Graul, Ph.D., Promoted to Chief Executive Officer
Mittwoch 7 August 2024 (5 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 7 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 14 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 26 Januar 2024 (12 Monate vor) • Edgar (US Regulatory)

Weitere Cyclerion Therapeutics Inc News-Artikel

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen